🔎 Trials Near Me

Utama › COPD › Maryland › Baltimore

Kajian klinikal COPD di Baltimore, MD

14 kajian untuk COPD sedang mencari peserta di lokasi dalam dan sekitar Baltimore (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Mengambil pesertaFasa 3
  • Johns Hopkins Bayview Medical Center- Site Number : 8400076, Baltimore
Umur 40 hingga 80 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07190222

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Mengambil pesertaFasa 4
  • Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
Umur 40 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07053423

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Mengambil pesertaFasa 2
  • Research Site, Baltimore
  • Research Site, Baltimore
Umur 40 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Mengambil pesertaFasa 2
  • Johns Hopkins University, Baltimore
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Mengambil pesertaFasa 3
  • Research Site, Baltimore
  • Research Site, Rosedale · 6 mi jauh
Umur 40 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Mengambil pesertaFasa 3
  • Research Site, Baltimore
Umur 40 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06883305

STRIVE Post-Market Registry Study

Mengambil pesertaKajian pemerhatian
  • University of Maryland, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT04302272

Multi-Center Clean Air Randomized Controlled Trial in COPD

Mengambil pesertaFasa 3
  • University of Maryland, Baltimore
  • Johns Hopkins, Baltimore
Umur 40 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06376994

SPIROMICS Study of Early COPD Progression (SOURCE)

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Johns Hopkins Bayview Medical Center, Baltimore
Umur 30 hingga 55 · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05033990

OMEGA - Dietary Intervention - COPD Trial

Mengambil peserta
  • Johns Hopkins Bayview Campus, Baltimore
Umur 40 ke atas · Semua jantina · Dikemas kini 16 Mac 2026 · NCT05297279

Trial to Determine Effective Aspirin Dose in COPD

Mengambil pesertaFasa 3
  • Johns Hopkins Bayview Medical Center, Baltimore
Umur 40 hingga 80 · Semua jantina · Dikemas kini 16 Mac 2026 · NCT05265299

Effectiveness of the WearME System for COPD Severity and Respiratory Function

Mengambil pesertaKajian pemerhatian
  • Johns Hopkins, Baltimore
Umur 21 hingga 100 · Semua jantina · Dikemas kini 9 Sep 2025 · NCT06751537

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Mengambil pesertaKajian pemerhatian
  • Ascension St. Agnes Hospital, Baltimore
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Mengambil peserta
  • University of Maryland - Baltimore, Baltimore
Umur 30 ke atas · Semua jantina · Dikemas kini 6 Feb 2025 · NCT05204888

Kajian COPD di bandar lain

Kajian lain di Baltimore

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.